Abstract
Studies on the Caco-2 cell monolayer system that contained cytochrome P450 and P-glycoprotein activities had advanced the theory that increased intestinal metabolism resulted with increased drug efflux due to an increase in mean residence time (MRT) in the system. To confirm or refute the claim, we developed compartmental models to study the effects of intestinal secretion on the MRT and rates of metabolism under first-order and nonlinear conditions. The theoretical examinations showed that under first-order conditions, intestinal secretion increased the MRT of drug in all compartments but failed to increase the rate of metabolite formation or the total amount of metabolite formed. Instead, reduced metabolic rates arose with increased efflux from cell, either into the apical or the basolateral compartment. By contrast, under saturable metabolic conditions, there were some conditions found whereby rates of metabolism increased with intestinal secretion and rapid reabsorption, albeit the total amount of metabolite formed eventually equaled the administered dose. Intestinal secretion failed to induce higher rates of metabolism for other conditions (saturable cellular binding, cellular efflux, or cell entry). With saturation of metabolic enzymes, drug efflux brought about desaturation, and, upon rapid recovery of drug into the cellular compartment, higher rates of metabolite formation were attained. The simulation study showed that, under first-order conditions, intestinal secretion reduced the rate of metabolism even though the MRT was prolonged within the cell preparation. With nonlinear metabolism, however, instances may exist whereby higher rates of metabolism would result with secretion.
Footnotes
-
↵1 Abbreviations used are: Pgp, P-glycoprotein; AUC, area under the curve; MRT, mean residence time for drug; CLd1 and CLd2, CLd1{mi} and CLd2{mi}, transfer clearances from basolateral compartment to cell, and from cell to basolateral compartment, for drug and metabolite mi, respectively; CLint,met, metabolic intrinsic clearance for drug; CLint,sec and CLint,sec{mi}, secretory intrinsic clearances for drug and metabolite, respectively; fap, fcell, and fbaso, unbound fractions of drug in the apical, cell, and basolateral compartment, respectively; ka and ka{mi}, absorption rate constants for drug and metabolite, respectively; AUMC, area under the moment curve.
-
This work was supported by the Canadian Institute for Health Research, Grant MOP36457. D.T. was a recipient of a Natural Sciences and Engineering Research Council of Canada summer studentship.
- Received February 24, 2003.
- Accepted June 25, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|